Xolair Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials
• Forums

A Prospective Study on Optimizing Treatment for ABPA
Condition:   Allergic Bronchopulmonary Aspergillosis Interventions:   Drug: Prednisone tablet;   Drug: itraconazole;   Biological: Omalizumab Sponsor:   Shanghai Zhongshan Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2021 Category: Research Source Type: clinical trials

Rilzabrutinib for the Treatment of Chronic Spontaneous Urticaria in Patients Who Remain Symptomatic Despite the Use of H1 Antihistamine and Who Are na ïve to Omalizumab
Condition:   Chronic Spontaneous Urticaria Interventions:   Drug: rilzabrutinib;   Drug: placebo Sponsor:   Sanofi Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 4, 2021 Category: Research Source Type: clinical trials